18F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease

Christopher Kobylecki; Tobias Langheinrich; Rainer Hinz; Emma R.L.C. Vardy; Gavin Brown; María-Elena Martino; Cathleen Haense; Anna M. Richardson; Alexander Gerhard; Jose M. Anton-Rodriguez; Julie S. Snowden; David Neary; Michael J. Pontecorvo; Karl Herholz

doi:10.2967/jnumed.114.147454

Research ArticleClinical Investigations

¹⁸F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease

Christopher Kobylecki, Tobias Langheinrich, Rainer Hinz, Emma R.L.C. Vardy, Gavin Brown, María-Elena Martino, Cathleen Haense, Anna M. Richardson, Alexander Gerhard, Jose M. Anton-Rodriguez, Julie S. Snowden, David Neary, Michael J. Pontecorvo and Karl Herholz

Journal of Nuclear Medicine March 2015, 56 (3) 386-391; DOI: https://doi.org/10.2967/jnumed.114.147454

Christopher Kobylecki

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tobias Langheinrich

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rainer Hinz

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Emma R.L.C. Vardy

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

3Institute of Neuroscience and Newcastle University Institute of Ageing, Newcastle University, Newcastle upon Tyne, United Kingdom

4Department of Older Peoples Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gavin Brown

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

María-Elena Martino

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

5Unidad de Medicina y Cirugía Experimental, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cathleen Haense

6Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anna M. Richardson

2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom

7Manchester Medical School, University of Manchester, Manchester, United Kingdom; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexander Gerhard

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jose M. Anton-Rodriguez

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Julie S. Snowden

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Neary

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael J. Pontecorvo

8Avid Radiopharmaceuticals, Philadelphia, Pennsylvania

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Karl Herholz

1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 56, Issue 3

March 1, 2015

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 18F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

¹⁸F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease

Journal of Nuclear Medicine Mar 2015, 56 (3) 386-391; DOI: 10.2967/jnumed.114.147454

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

¹⁸F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease

Journal of Nuclear Medicine Mar 2015, 56 (3) 386-391; DOI: 10.2967/jnumed.114.147454

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Amyloid Imaging in Dementia: Contribution or Confusion?
This Month in JNM

PubMed
Google Scholar

Cited By...

Traumatic brain injury and Alzheimers Disease biomarkers: A systematic review of findings from amyloid and tau positron emission tomography (PET)
Amyloid-PET-Positive Patient With bvFTD: Wrong Diagnosis, False Positive Scan, or Copathology?
Derivation and utility of an A{beta}-PET pathology accumulation index to estimate A{beta} load
Current Status of 18F-FDG PET Brain Imaging in Patients with Dementia
Alzheimer Disease: Approaches to Early Diagnosis and High-Accuracy Imaging
Amyloid Imaging in Dementia: Contribution or Confusion?

Google Scholar

Keywords

amyloid
PET
Alzheimer’s disease
frontotemporal dementia
diagnosis

Main menu

User menu

Search

¹⁸F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords